Back to Results
First PageMeta Content
Piperidines / Atypical antipsychotics / Organofluorides / Lactams / Paliperidone / Antipsychotic / Risperidone / Ondansetron / Schizoaffective disorder / Organic chemistry / Chemistry / Psychiatry


Pediatric Focused Safety Review: Invega Extended Release Tablets (paliperidone)
Add to Reading List

Open Document

File Size: 199,53 KB

Share Result on Facebook

Company

Janssen Pharmaceuticals Inc. / /

Event

FDA Phase / /

MedicalCondition

Schizoaffective disorder / related disorders / Schizophrenia / /

MedicalTreatment

antidepressant therapy / /

Organization

Pediatric Advisory Committee / New Drugs Center for Drug Evaluation / Food and Drug Administration / Maternal Health Staff Office / /

Person

Alyson Karesh / /

Product

Extended-Release Tablets / Risperidone / Invega / Written Request Invega® (paliperidone) / /

SocialTag